Clinical trials

On the path to adoption of decentralised clinical trials

By Wendi M Lau2021-12-23T10:38:00

AdobeStock_439443935

Source: Adobe Stock

Decentralised clinical trials (DCTs) offer great potential to improve the clinical trial paradigm, bringing more diversity and less burden to the participants we serve. COVID-19 has driven DCTs, offering greater flexibility to clinical trial patients. More needs to be done to make DCTs a standard option.

 This is member-only content

To read this article, SIGN IN NOW if you are a TOPRA member.

Not a TOPRA member yet? 

Join now to get access to:

  • Features and specialist articles
  • CPD supplements
  • Comprehensive archive

Become a member today!

Not sure yet?  Read one of our free editorials to see what you’re missing out on!